Must have histopathologically/cytologically confirmed primary tumors for which docetaxel is an appropriate or reasonable treatment option [clinicaltrials_resource:455f623df46ac8d983b8f53e10fc11d2]
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
Must have histopathologically/cytologically confirmed primary tumors for which docetaxel is an appropriate or reasonable treatment option [clinicaltrials_resource:455f623df46ac8d983b8f53e10fc11d2]
Bio2RDF identifier
455f623df46ac8d983b8f53e10fc11d2
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:455f623df46ac8d983b8f53e10fc11d2
identifier
clinicaltrials_resource:455f623df46ac8d983b8f53e10fc11d2
title
Must have histopathologically/ ...... or reasonable treatment option
@en
type
label
Must have histopathologically/ ...... f623df46ac8d983b8f53e10fc11d2]
@en